Abstract
The stability of proteins is an important factor for industrial and medical applications. Improving protein stability is one of the main subjects in protein engineering. In a previous study, we improved the stability of a four-helix bundle dimeric de novo protein (WA20) by five mutations. The stabilised mutant (H26L/G28S/N34L/V71L/E78L, SUWA) showed an extremely high denaturation midpoint temperature (Tm). Although SUWA is a remarkably hyperstable protein, in protein design and engineering, it is an attractive challenge to rationally explore more stable mutants. In this study, we predicted stabilising mutations of WA20 by in silico saturation mutagenesis and molecular dynamics simulation, and experimentally confirmed three stabilising mutations of WA20 (N22A, N22E, and H86K). The stability of a double mutant (N22A/H86K, rationally optimised WA20, ROWA) was greatly improved compared with WA20 (ΔTm = 10.6 °C). The model structures suggested that N22A enhances the stability of the α-helices and N22E and H86K contribute to salt-bridge formation for protein stabilisation. These mutations were also added to SUWA and improved its Tm. Remarkably, the most stable mutant of SUWA (N22E/H86K, rationally optimised SUWA, ROSA) showed the highest Tm (129.0 °C). These new thermostable mutants will be useful as a component of protein nanobuilding blocks to construct supramolecular protein complexes.
Subject terms: Biochemistry, Biochemistry, Biological physics
Introduction
Improving the stability of proteins is one of main subjects in protein engineering. Development of methods to stabilise proteins will contribute to medical and industrial applications. For many years, stabilisation of various proteins has been studied in the fields of protein engineering1–6. Many studies on protein stabilisation by mutagenesis have been reported, but investigating sufficient mutations of amino-acid residues requires enormous effort and cost for experiments. Several computational methods have been used to rationally predict stabilising mutations7,8. Because proteins are dynamic molecules in solution and molecular dynamics (MD) simulation provides information about the dynamic behaviour of molecules in variable environments in silico, MD simulation is useful for designing stabilised proteins9.
Protein design is also a main and hot topic in protein engineering10–13. As a semirational approach for protein design, the binary code strategy was developed to construct libraries of novel polypeptides (de novo proteins) that would fold into predetermined structures14. Using secondary structure motifs with binary patterns of polar and nonpolar residues, de novo proteins with α-helices or β-sheets have been successfully created without reference to natural protein sequences. WA20 is one of the de novo proteins obtained from a library of binary patterned four-helix bundles15. Previously the crystal structure of WA20 was solved, revealing an intermolecularly folded dimeric four-helix bundle (PDB ID: 3VJF)16 with a bisecting U topology17. Moreover, utilising the characteristic dimeric structure of WA20 as a component, protein nanobuilding blocks (PN-Blocks)18,19 were developed to construct self-assembled supramolecular nanostructures: WA20-foldon, constructed by fusing dimeric WA20 to a trimeric foldon domain of T4 phage fibritin formed several types of self-assembled nanoarchitectures, including a barrel-like hexamer and a tetrahedrally shaped dodecamer18. In addition, extender protein nanobuilding blocks (ePN-Blocks) was constructed by tandemly joining two copies of WA20 with various linkers19. The ePN-Blocks self-assembled into cyclised and extended chain-type nanostructures.
With the long-term goal of producing nanostructures with extremely high stabilities for applications in nanotechnology, we were motivated to stabilise the designed protein WA20, a main component of PN-Blocks. Recently, we succeeded in dramatically improving the stability of WA20 by introducing five amino acid substitutions (H26L, G28S, N34L, V71L, and E78L)20 to enhance the hydrophobic core and α-helix stability based on the WA20 structure. This mutant, which is called super WA20 (SUWA), showed an extremely high denaturation midpoint temperature (Tm) above the boiling point of water.
Although SUWA is a remarkably hyperstable protein, in protein engineering, it is an attractive challenge to rationally explore more stable mutants than the de novo designed proteins WA20 and SUWA. In this study, we performed rational design of new mutations to stabilise WA20 and SUWA by in silico mutagenesis and MD simulation. Three mutations (N22A, N22E, and H86K) were found to improve Tm of WA20. A double mutant of WA20 (N22A/H86K, which is called rationally optimised WA20, ROWA) greatly improved Tm by 10.6 °C. Moreover, these mutations improved the thermostability of SUWA. In particular, a double mutant of SUWA (N22E/H86K, which is called rationally optimised SUWA, ROSA) showed the highest Tm of 129.0 °C. In addition, the ROWA and ROSA oligomers were characterised by size exclusion chromatography–multi-angle light scattering (SEC–MALS) and small-angle X-ray scattering (SAXS).
Results
Prediction of mutations to stabilise WA20
For soluble and stable proteins, generally, most of the amino acid residues on the surface of the proteins are hydrophilic and most of the residues inside the proteins are hydrophobic. However, in some cases, there are some unusual residues, which are hydrophilic residues buried inside the protein, that can be potentially optimised. Therefore, to select target residues for mutations, we searched for hydrophilic residues buried in the WA20 protein structure based on the accessible surface area (ASA) per residue (Supplementary Table S1). Five hydrophilic residues buried inside the structure of WA20 (H26, H74, E78, S79, and H86) were found based on small ASA ratios (ASA ratio ≤ 0.11 in both the A and B chains). In addition, we chose two target residues (N22 and N34) on the interface of the α-helices to potentially enhance the helix–helix interactions (Supplementary Fig. S1). In a previous study of SUWA20, we tested some mutations (H26L/E78L and N34L) at these target residue sites. The double mutation H26L/E78L significantly improved Tm of WA20 by 26 °C and the single mutation N34L improved Tm by 10°C20. Therefore, in the present study, we focused on the target residues (N22, H74, S79, and H86, Fig. 1) that we did not test previously.
Saturation mutagenesis is an exhaustive search for all possible mutations of 19 amino acids at a target site, but enormous effort and cost are required for experiments. Hence, we attempted to predict stabilising mutations using MD simulation. First, we performed high-temperature MD simulations of WA20 and the mutants constructed in a previous study (G28S, N34L, V71L, H26L/E78L, H26L/G28S/V71L/E78L, and SUWA)20. The root mean square deviations (RMSDs) between the initial structures and the structures after high-temperature MD simulations were calculated to evaluate the degree of protein unfolding. The RMSD values of WA20 and the mutants showed a strong negative correlation with Tm of the mutants (r = − 0.966, p = 5.461 × 10−5, Supplementary Fig. S2), suggesting that RMSD is a useful indicator to evaluate the stability of mutants. Therefore, we performed high-temperature MD simulations of all of the possible single mutants and the original WA20 (i.e., in silico saturation mutagenesis) at the four target residue sites (N22, H74, S79, and H86). Based on the MD simulation results, we selected eight mutations of WA20 with small RMSD values (N22A, N22E, N22K, N22L, H86K, H86S, H74V, and S79F, Supplementary Fig. S3) for subsequent experiments. At the N22 site, the N22G mutation showed the smallest RMSD value, but we did not adopt N22G because the RMSD values of N22G showed relatively large variability and glycine is generally unfavourable in an α-helix of proteins21. Because the H74 and S79 sites are close, we constructed the double mutant of H74V/S79F with one oligo-DNA primer for the site-directed mutations.
Development of stabilised mutants of WA20
WA20 and the mutant proteins were expressed in Escherichia coli and purified by immobilised metal ion affinity chromatography (IMAC) (Supplementary Fig. S4). The circular dichroism (CD) spectra at 25 °C showed that all of the mutants formed α-helical structures, as well as the parental WA20 protein (Fig. 2A and Supplementary Fig. S5).
Thermal denaturation experiments (Table 1 and Supplementary Fig. S6) revealed that the N22A, N22E, and H86K mutants had higher midpoint temperatures than WA20 (ΔTm of 2.9 °C for N22A, 1.0 °C for N22E, and 3.5 °C for H86K). In contrast, the N22K and N22L mutations considerably reduced the stability (Table 1).
Table 1.
Sample | Tm (°C) | ΔTm (°C) |
---|---|---|
WA20 | 69.8 ± 0.4 | – |
N22A | 72.7 ± 0.6 | 2.9 |
N22E | 70.8 ± 0.5 | 1.0 |
N22K | 60.9 ± 1.0 | − 8.9 |
N22L | 65.0 ± 0.9 | − 4.8 |
H86K | 73.3 ± 0.7 | 3.5 |
H86S | 68.6 ± 0.8 | − 1.2 |
H74V/S79F | 69.9 ± 1.2 | 0.1 |
N22A/H86K (ROWA) | 80.4 ± 3.5 | 10.6 |
N22E/H86K | 71.7 ± 1.1 | 1.9 |
To test combination of these stabilising mutations, we constructed two double mutants of WA20: N22A/H86K and N22E/H86K. The N22A/H86K mutant (ROWA), remarkably improved the stability (ΔTm = 10.6 °C) compared with the parental WA20 protein (Fig. 2B and Table 1).
Development of stabilised mutants of SUWA
We also added the three stabilising mutations (N22A, N22E, and H86K) to SUWA, which is the hyperstable mutant (H26L/G28S/N34L/V71L/E78L) of WA20 constructed in a previous study20. Three single mutants (N22A, N22E, and H86K) and two double mutants (N22A/H86K and N22E/H86K) of SUWA were constructed, expressed in E. coli, and purified by IMAC (Supplementary Fig. S7). For the SUWA_N22E and SUWA_N22E/H86K mutants, the yields of the purified proteins improved compared with SUWA (amount of purified protein per litre of culture of ~ 22 mg for SUWA_N22E, ~ 19 mg for SUWA_N22E/H86K, and ~ 6 mg for SUWA). The CD spectra at 30 °C showed that all of the mutants of SUWA formed α-helical structures, as well as the SUWA protein (Fig. 2C and Supplementary Fig. S8). Thermal denaturation experiments revealed that all of the mutants of SUWA had higher midpoint temperatures than SUWA (Table 2, Fig. 2D, and Supplementary Fig. S6D). Compared with SUWA, the single mutations N22A, N22E, and H86K improved Tm by 3.8, 1.1, and 0.9 °C, and the double mutations N22A/H86K and N22E/H86K improved Tm by 3.8 and 4.3 °C, respectively. We call the mutant with the highest Tm (SUWA_N22E/H86K, Tm = 129.0 °C) ROSA.
Table 2.
Sample | Tm (°C) | ΔTm (°C) |
---|---|---|
SUWA | 124.7 ± 0.1 | – |
SUWA_N22A | 128.5 ± 0.1 | 3.8 |
SUWA_N22E | 125.8 ± 0.1 | 1.1 |
SUWA_H86K | 125.6 ± 0.3 | 0.9 |
SUWA_N22A/H86K | 128.5 ± 0.5 | 3.8 |
SUWA_N22E/H86K (ROSA) | 129.0 ± 0.1 | 4.3 |
Characterisation of ROWA and ROSA oligomers
To evaluate the oligomeric states of the ROWA and ROSA proteins in solution, SEC–MALS experiments were performed (Fig. 3). The molecular mass for each peak of the ROWA and ROSA proteins was determined (Table 3). The oligomeric number of each peak was calculated using the theoretical molecular mass values of monomers of ROWA (12.5 kDa) and ROSA (12.6 kDa). The ROWA protein mainly formed a dimer (peak (i), 77%), and it also formed a tetramer (peak (ii), 21%) and a hexamer (peak (iii), 2%). The ROSA protein mainly formed a dimer (peak (i), 64%), and it also formed a tetramer (peak (ii), 18%), a hexamer (peak (iii), 7%), and higher oligomers (peak (iv), 11%). Although the parental WA20 and SUWA proteins only formed dimers16,20, the ROWA and ROSA proteins formed not only dimers, but also some larger oligomers (tetramers, hexamers, and higher oligomers), suggesting that the introduced mutations increase the interactions forming larger oligomers.
Table 3.
Sample (peak) | Mw (kDa) | Oligomeric number (mer) | Mass fraction (%) |
---|---|---|---|
ROWA (i) | 22.8 | 2 | 77 |
ROWA (ii) | 45.3 | 4 | 21 |
ROWA (iii) | 72.8 | 6 | 2 |
ROSA (i) | 23.4 | 2 | 64 |
ROSA (ii) | 49.2 | 4 | 18 |
ROSA (iii) | 81.2 | 6 | 7 |
ROSA (iv) | 238 | 19 | 11 |
In addition, the SEC profiles of the isolated dimer peak fractions of ROWA and ROSA did not change after one week (Supplementary Fig. S9), suggesting that the oligomeric states are stable and do not exchange to the other oligomeric states on a timescale of a week at room temperature.
SAXS analysis
To further analyse the ROWA and ROSA oligomers, we performed SAXS experiments (Fig. 4A,B) of the samples fractionated by SEC purification. The weight-average molecular mass (Mw) values of the ROWA and ROSA samples (except for ROSA (iii + iv)) (Table 4) calculated from Guinier plots (Supplementary Fig. S10) were consistent with those from the SEC–MALS experiments (Table 3).
Table 4.
Sample | I(q → 0)/c (cm−1 mg−1 mL) | Dmax (nm) | Rg (nm) | Mw (kDa) |
---|---|---|---|---|
ROWA (i) | 0.01501 | 9.90 | 2.45 | 25.0 |
ROWA (ii) | 0.02804 | 18.1 | 4.09 | 46.8 |
ROWA (iii) | 0.04034 | 24.8 | 5.25 | 67.3 |
ROSA (i) | 0.01497 | 10.6 | 2.50 | 25.0 |
ROSA (ii) | 0.03022 | 22.1 | 4.42 | 50.4 |
Ovalbumin | 0.02657 | 8.19 | 2.45 | 44.3a |
aOvalbumin was used as a reference standard of the molecular mass.
To extract intuitive real-space information from the SAXS data, we obtained the pair-distance distribution functions (p(r)) reflected by the shapes of the ROWA and ROSA oligomers by the indirect Fourier transformation (IFT) technique (Fig. 4C,D). The shapes of p(r) for all of the samples of ROWA and ROSA were characterised by an extended tail in the high-r region, suggesting formation of rod-like elongated shapes similar to WA20 and SUWA. The Dmax values of ROWA (i) (dimer), ROWA (ii) (tetramer), ROWA (iii) (hexamer), ROSA (i) (dimer), ROSA (ii) (tetramer), and ROSA (iii + iv) (hexamer and higher oligomers) indicated that the larger oligomers formed longer shapes (Fig. 4C,D and Table 4).
Low-resolution dummy atom models were reconstructed from the SAXS data (Fig. 5 and Supplementary Fig. S11). The ab initio dummy atom models of the ROWA and ROSA dimers (Fig. 5A(i),B(i)) were almost the same shapes as structures of the WA20 and SUWA dimers. Interestingly, the dummy atom models of the ROWA and ROSA tetramers (Fig. 5A(ii),B(ii)) and the ROWA hexamer (Fig. 5A(iii)) were more elongated than those of the dimers.
Discussion
Thermal denaturation is one of the main problems that limit industrial and medical use of proteins. However, experimental searches for stabilising mutations by saturation mutagenesis require enormous effort and cost because there are potentially 19 candidate amino acids at each target residue site. In this study, we attempted to discover rationally stabilising mutations of the de novo protein WA20 by MD simulation. At the four target residue sites (N22, H74, S79, and H86), we selected seven mutations of WA20 (N22A, N22E, N22K, N22L, H86K, H86S, and H74V/S79F) based on in silico saturation mutagenesis and high-temperature MD simulations. Three mutations improving Tm of WA20 (N22A, N22E, and H86K, Table 1) were found. We then examined combinations of these mutations. While both double mutations (N22A/H86K and N22E/H86K) stabilised WA20, the contributions of these mutations to thermostabilisation may be different (Table 1). Because ΔTm of N22A/H86K (10.6 °C) is greater than the sum of the ΔTm values of N22A (2.9 °C) and H86K (3.5 °C), combination of these mutations synergistically contributes to the protein stability. In contrast, ΔTm of N22E/H86K (1.9 °C) is less than ΔTm of H86K (3.5 °C), indicating that the combination of N22E and H86K may have a negative effect for the stability of WA20.
We also added the three mutations (N22A, N22E, and H86K) to SUWA, which is the hyperstable mutant of WA20 with five mutations (H26L, G28S, N34L, V71L, and E78L) developed in a previous study20. Three single mutations (N22A, N22E, and H86K) and two double mutations (N22A/H86K and N22E/H86K) of SUWA improved Tm (Table 2). In particular, the combination of N22E and H86K mutations (ROSA) greatly improved the thermostability. As in the case of ROSA, ΔTm of N22E/H86K (4.3 °C) is greater than the sum of the ΔTm values of N22E (1.1 °C) and H86K (0.9 °C), suggesting that the combination of these mutations synergistically contributes to the protein stability. These results suggest that MD simulation is useful for finding stabilising mutations.
Structural models of the mutants (N22A, N22E, and H86K) of WA20 and SUWA suggest possible mechanisms for stabilisation of the structures (Supplementary Fig. S12). In the structures of the WA20 and SUWA dimers, two N22 residues are located near the R25 residues on the interface of the helices in both chains A and B (Supplementary Fig. S12A). In many natural proteins, alanine is the amino acid that has a preference to make an α-helix21. The N22A mutation can promote formation of α-helices and improve the structural stability. In contrast, the N22E mutation can electrostatically stabilise the protein structure by intra- and inter-chain interactions with R25 (Supplementary Fig. S12A).
Conversely, the N22K and N22L mutations destabilise the WA20 protein. Two lysine residues (N22K) and two arginine residues (R25) electrostatically repel one another (Supplementary Fig. S13). The leucine residues (N22L) may destabilise the structure probably because of exposure of large hydrophobic side chains on the interface of the helices to the solution (Supplementary Fig. S13).
In both the WA20 and SUWA structures, H86 interacts with D72 (Supplementary Fig. S12B). In neutral pH conditions, lysine has more positive charge than histidine, and thus the lysine residues (H86K) form stronger ionic bonds with the aspartic acid residues (D72), contributing to the thermostability (Supplementary Fig. S12B).
Several stabilised mutants of WA20 and SUWA, such as ROWA and ROSA developed in this study, have advantages for constructing supramolecular complexes of protein nanobuilding blocks (PN-Blocks)18,19. In particular, the ROSA protein achieved extremely high thermostability (Tm = 129.0 °C) and the protein expression level of ROSA in E. coli improved compared with SUWA. Therefore, ROSA is expected to improve the thermal stability and productivity of PN-Blocks, contributing to protein engineering and synthetic biology.
Methods
Selection of the target residue sites for mutations
Candidates for the target residues for mutations of WA20 were selected based on the ASA (Table S1) in the crystal structure of WA20 (PDB ID: 3VJF)16 calculated by the program AREAIMOL22,23 in the CCP4 suite24. The hydrophilic residues (H26, H74, E78, S79, and H86) buried inside were selected (ASA ratio to calculated GXG value ≤ 0.11). In addition, target residues on the interface of α-helices (N22 and N34) were selected by manual inspection of the crystal structure of WA20 to potentially enhance helix–helix interactions. Because some mutations (H26L/E78L and N34L) at the candidate residue sites had already been tested in a previous study of SUWA20, in the present study, we investigated the target residues (N22, H74, S79, and H86) that had not been previously tested.
MD simulation
The mutant structures were generated from the crystal structure of WA20 (PDB ID: 3VJF)16 or SUWA (PDB ID: 6KOS)20 using the Scwrl4 program25. The MD simulations were performed with the GROMACS 2016 molecular simulation package26. The proteins were protonated and dissolved in a dodecahedral box and placed at least 2.0 nm from the box edges. Periodic boundary conditions were applied in all directions. The box was filled with water molecules. Sodium and chloride ions were added to each box to neutralise the total charge. The AMBER ff14SB force field27 was used to represent the proteins and the TIP3P model28 was used for water. After energy minimisation, constant-pressure and constant-temperature (NPT) MD simulations were performed at 1 bar and 300 K for 0.1 ns, and then the production runs were performed at 600 K for 10 ns with ten random seeds for each mutant in the NVT ensemble (constant temperature and volume). The Berendsen method was used to maintain the pressure during the NPT simulation29. Langevin dynamics was used to control the temperature with water viscosity set to 2 ps−1. The covalent bonds of the hydrogen atoms in the proteins were constrained using the LINCS method30, and the integration time step was 2.0 fs. During the production run, the coordinates were saved every 100 ps. The RMSD between the structures before and after the production runs was calculated by the GROMACS tool.
Construction of protein expression plasmids
The protein expression plasmids of the mutants of WA20 and SUWA were prepared by site-directed mutagenesis of the plasmid pET3-WA2016 or pET3-SUWA20 using the transfer-PCR method31 with the oligo-DNA primers (Table S2) and KOD-Plus-Neo DNA polymerase (Toyobo, Osaka, Japan). The amino acid sequences of the WA20, ROWA, SUWA, and ROSA proteins are shown in Supplementary Fig. S14.
Protein expression and purification
The WA20, SUWA, and mutant proteins were expressed in E. coli BL21 Star (DE3) (Invitrogen, Carlsbad, CA, USA) harbouring an expression plasmid in 1 L of LB broth, Lennox (Nacalai Tesque, Kyoto, Japan) containing 100 µg/mL ampicillin sodium salt at 37 °C for 16 h. All the proteins were expressed in E. coli without isopropyl β-d-thiogalactopyranoside induction. The proteins were extracted from the harvested cells by freezing–thawing and sonication with a VC 505 ultrasonic processor (Sonics and Materials, Newtown, CT, USA) in 50 mM sodium phosphate buffer (pH 7.0) containing 300 mM NaCl and 10% glycerol. The proteins were purified by immobilised metal affinity chromatography (IMAC) with TALON metal affinity resin (Takara Bio, Kusatsu, Shiga, Japan). Because many histidine residues are exposed on the surface of the WA20 and SUWA structures16,20, WA20, SUWA, and their mutants without His-tag can bind to the IMAC resin. The resin was washed with 50 mM sodium phosphate buffer (pH 7.0) containing 300 mM NaCl and 10% glycerol, and the proteins were eluted with 50 mM sodium phosphate buffer (pH 7.0) containing 300 mM NaCl, 10% glycerol, and 200 mM imidazole. The protein concentration was determined by absorbance at 280 nm using a NanoDrop Lite spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA). The molar extinction coefficient of each protein was calculated according to the amino acid sequence (Trp: 5559, Tyr: 1197, and Phe: 0.7)32.
CD spectroscopy
For the thermal denaturation experiments, we used a J-1500 spectropolarimeter (JASCO, Hachioji, Tokyo, Japan) specially equipped with a programmable temperature controller and a pressure-proof cell compartment that prevented the aqueous solution from boiling and evaporating at high temperatures. Thermal denaturation was monitored at the ellipticity of a typical peak of the α-helices of proteins (θ222nm) using the cell compartment pressured by nitrogen gas (+ 0.5 MPa). Each protein (∼0.3 mg/mL) was dissolved in 20 mM sodium phosphate buffer (pH 7.5) containing 150 mM NaCl and 10% glycerol. A cell with 0.1 cm path length was used. The temperature was increased at a rate of 2.0 °C/min. The thermal denaturation curves were analysed to calculate the denaturation midpoint temperatures (Tm) using CDpal33, version 2.18. The data were fitted to a two-state model with ΔCp fixed to zero. The errors were estimated by the CDpal program using the robust jackknife method33.
SEC–MALS
The SEC–MALS experiments were performed using an Alliance e2695 HPLC system (Waters, Milford, MA, USA) equipped with a Superdex 75 Increase 10/300 GL column (Cytiva, Little Chalfont, Buckinghamshire, UK), which was connected in line with a DAWN HELEOS II multi-angle static light scattering detector (Wyatt Technology, Santa Barbara, CA). The data were collected at 20 °C with 20 mM HEPES buffer (pH 7.5) containing 150 mM NaCl and 5% glycerol and analysed using ASTRA 6 software (Wyatt Technology)34. The dn/dc value of 0.185 mL/g was generally used for the proteins with extinction coefficients of 0.542 mL mg−1 cm−1 for ROWA and 0.539 mL mg−1 cm−1 for ROSA calculated according to the amino acid sequences.
SAXS
For the SAXS experiments, the ROWA and ROSA samples after IMAC purification were further purified by SEC (20 mM HEPES buffer (pH 7.5) containing 150 mM NaCl and 5% glycerol) with a Superdex 75 Increase 10/300 GL column (Cytiva). SAXS measurements were performed for samples (~ 1–4 mg/mL) of ROWA, ROSA, and chicken ovalbumin (A7641; Sigma-Aldrich, St. Louis, MO, USA) dissolved in the HEPES buffer at 20 °C using synchrotron radiation (λ = 1.3 Å) at the Photon Factory BL-10C beamline35 (KEK, Tsukuba, Japan) with a PILATUS3 2 M detector (Dectris, Baden, Switzerland) at a sample-detector distance of 1.08 m.
The two-dimensional scattering images were integrated into one-dimensional scattering intensities I(q) as a function of the magnitude of the scattering vector q = (4π/λ)sin(θ/2) using SAngler36, where θ is the total scattering angle.
The IFT technique was used to calculate the pair-distance distribution function p(r) using GNOM37 in the ATSAS program suite38. The forward scattering intensity, I(q → 0), and radius of gyration, Rg, were estimated by Guinier approximation39 using AUTORG in ATSAS38 with SAngler36. Assuming that the proteins have practically the same scattering length density and specific volume and that the structure factor is almost unity (S(q) ≈ 1) for the dilute samples, the forward scattering intensity normalised by the protein concentration (mg/mL), I(q → 0)/c, is proportional to the weight average molecular mass (Mw). Ovalbumin (Mw = 44.3 kDa) was used as a reference standard of the molecular mass.
The low-resolution dummy atom models were constructed from the SAXS data using the ab initio shape modelling programs in the ATSAS program suite38 for small-angle scattering data analysis from biological macromolecules. The calculations of rapid ab initio shape determination were performed ten times by DAMMIF40 without a symmetry constraint, and the generated models were aligned and averaged by DAMAVER41. The averaged model was modified with the fixed core by DAMSTART and further refinement of the model was performed by DAMMIN42. The images of the dummy atom models were prepared using UCSF Chimera43, version 1.12. The SAXS data and dummy atom models of ROWA and ROSA have been deposited into Small Angle Scattering Biological Data Bank (SASBDB)44,45 (accession codes: SASDKM8 for ROWA dimer, SASDKN8 for ROWA tetramer, SASDKP8 for ROWA hexamer, SASDKQ8 for ROSA dimer, and SASDKR8 for ROSA tetramer).
Modelling of the mutant structures
The model structures of the mutants were constructed based on the crystal structure of WA20 (PDB ID: 3VJF)16 or SUWA (PDB ID: 6KOS)20 using the Scwrl4 program25. The model structures were optimised by MD simulation at 300 K for 1 ns. The structure images were created using open-source PyMOL, version 2.4 (Schrödinger, New York, NY, USA).
Supplementary Information
Acknowledgements
We thank Prof. Michael Hecht at Princeton University for the kind gift of the expression plasmid of WA20, and Dr. Naoya Kobayashi, Dr. Takahiro Kosugi, Dr. Rie Koga, and Dr. Nobuyasu Koga at the Institute for Molecular Science (IMS) for assistance with the CD experiments. The SAXS and SEC–MALS experiments were performed at Photon Factory (PF), KEK, under the approval of the PF program advisory committee (Proposal Nos. 2016G606 and 2018G634). We thank the beamline scientists and staff at PF, KEK. We are indebted to Research Center for Supports to Advanced Science, Shinshu University for providing facilities. We thank Dr. Tim Cooper from Edanz Group for editing a draft of this manuscript in English. This work was supported by the New Energy and Industrial Technology Development Organization (NEDO) and JSPS KAKENHI Grant Numbers JP16K05841, JP17KK0104, and JP19H02522. This work was also supported by the Joint Research Program of IMS (IMS program No. 214).
Author contributions
T.K., M.U., T.M., and R.A. designed the study. K.K., Y.S., and T.K. performed and analysed the computational calculations. S.I. performed and analysed all of the experiments. S.I., K.K., T.K., and R.A. wrote the paper. All authors discussed the results and reviewed the manuscript.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
The online version contains supplementary material available at 10.1038/s41598-021-86952-2.
References
- 1.Russell RJ, Taylor GL. Engineering thermostability: lessons from thermophilic proteins. Curr. Opin. Biotechnol. 1995;6:370–374. doi: 10.1016/0958-1669(95)80064-6. [DOI] [PubMed] [Google Scholar]
- 2.Lehmann M, Wyss M. Engineering proteins for thermostability: the use of sequence alignments versus rational design and directed evolution. Curr. Opin. Biotechnol. 2001;12:371–375. doi: 10.1016/s0958-1669(00)00229-9. [DOI] [PubMed] [Google Scholar]
- 3.Wijma HJ, Floor RJ, Janssen DB. Structure- and sequence-analysis inspired engineering of proteins for enhanced thermostability. Curr. Opin. Struct. Biol. 2013;23:588–594. doi: 10.1016/j.sbi.2013.04.008. [DOI] [PubMed] [Google Scholar]
- 4.Yu HR, Huang H. Engineering proteins for thermostability through rigidifying flexible sites. Biotechnol. Adv. 2014;32:308–315. doi: 10.1016/j.biotechadv.2013.10.012. [DOI] [PubMed] [Google Scholar]
- 5.Magliery TJ. Protein stability: computation, sequence statistics, and new experimental methods. Curr. Opin. Struct. Biol. 2015;33:161–168. doi: 10.1016/j.sbi.2015.09.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Wheeler LC, Lim SA, Marqusee S, Harms MJ. The thermostability and specificity of ancient proteins. Curr. Opin. Struct. Biol. 2016;38:37–43. doi: 10.1016/j.sbi.2016.05.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Goldenzweig A, et al. Automated structure- and sequence-based design of proteins for high bacterial expression and stability. Mol. Cell. 2016;63:337–346. doi: 10.1016/j.molcel.2016.06.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Zimmerman MI, et al. Prediction of new stabilizing mutations based on mechanistic insights from Markov state models. ACS Cent. Sci. 2017;3:1311–1321. doi: 10.1021/acscentsci.7b00465. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Childers MC, Daggett V. Insights from molecular dynamics simulations for computational protein design. Mol. Syst. Des. Eng. 2017;2:9–33. doi: 10.1039/C6ME00083E. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Hill RB, Raleigh DP, Lombardi A, Degrado WF. De novo design of helical bundles as models for understanding protein folding and function. Acc. Chem. Res. 2000;33:745–754. doi: 10.1021/ar970004h. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Smith BA, Hecht MH. Novel proteins: from fold to function. Curr. Opin. Chem. Biol. 2011;15:421–426. doi: 10.1016/j.cbpa.2011.03.006. [DOI] [PubMed] [Google Scholar]
- 12.Huang PS, Boyken SE, Baker D. The coming of age of de novo protein design. Nature. 2016;537:320–327. doi: 10.1038/nature19946. [DOI] [PubMed] [Google Scholar]
- 13.Arai R. Hierarchical design of artificial proteins and complexes toward synthetic structural biology. Biophys. Rev. 2018;10:391–410. doi: 10.1007/s12551-017-0376-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Hecht MH, Das A, Go A, Bradley LH, Wei Y. De novo proteins from designed combinatorial libraries. Protein Sci. 2004;13:1711–1723. doi: 10.1110/ps.04690804. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Patel SC, Bradley LH, Jinadasa SP, Hecht MH. Cofactor binding and enzymatic activity in an unevolved superfamily of de novo designed 4-helix bundle proteins. Protein Sci. 2009;18:1388–1400. doi: 10.1002/pro.147. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Arai R, et al. Domain-swapped dimeric structure of a stable and functional de novo four-helix bundle protein, WA20. J. Phys. Chem. B. 2012;116:6789–6797. doi: 10.1021/jp212438h. [DOI] [PubMed] [Google Scholar]
- 17.Hill RB, DeGrado WF. Solution structure of α2D, a nativelike de novo designed protein. J. Am. Chem. Soc. 1998;120:1138–1145. doi: 10.1021/ja9733649. [DOI] [Google Scholar]
- 18.Kobayashi N, et al. Self-assembling nano-architectures created from a protein nano-building block using an intermolecularly folded dimeric de novo protein. J. Am. Chem. Soc. 2015;137:11285–11293. doi: 10.1021/jacs.5b03593. [DOI] [PubMed] [Google Scholar]
- 19.Kobayashi N, et al. Self-assembling supramolecular nanostructures constructed from de novo extender protein nanobuilding blocks. ACS Synth. Biol. 2018;7:1381–1394. doi: 10.1021/acssynbio.8b00007. [DOI] [PubMed] [Google Scholar]
- 20.Kimura N, Mochizuki K, Umezawa K, Hecht MH, Arai R. Hyperstable de novo protein with a dimeric bisecting topology. ACS Synth. Biol. 2020;9:254–259. doi: 10.1021/acssynbio.9b00501. [DOI] [PubMed] [Google Scholar]
- 21.Pace CN, Scholtz JM. A helix propensity scale based on experimental studies of peptides and proteins. Biophys. J. 1998;75:422–427. doi: 10.1016/s0006-3495(98)77529-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Lee B, Richards FM. The interpretation of protein structures: estimation of static accessibility. J. Mol. Biol. 1971;55:379–400. doi: 10.1016/0022-2836(71)90324-X. [DOI] [PubMed] [Google Scholar]
- 23.Saff EB, Kuijlaars ABJ. Distributing many points on a sphere. Math. Intell. 1997;19:5–11. doi: 10.1007/BF03024331. [DOI] [Google Scholar]
- 24.Winn MD, et al. Overview of the CCP4 suite and current developments. Acta Cryst. D. 2011;67:235–242. doi: 10.1107/S0907444910045749. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Krivov GG, Shapovalov MV, Dunbrack RL., Jr Improved prediction of protein side-chain conformations with SCWRL4. Proteins. 2009;77:778–795. doi: 10.1002/prot.22488. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Abraham MJ, et al. GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1–2:19–25. doi: 10.1016/j.softx.2015.06.001. [DOI] [Google Scholar]
- 27.Maier JA, et al. ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB. J. Chem. Theory Comput. 2015;11:3696–3713. doi: 10.1021/acs.jctc.5b00255. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 1983;79:926–935. doi: 10.1063/1.445869. [DOI] [Google Scholar]
- 29.Berendsen HJC, Postma JPM, Gunsteren WFV, DiNola A, Haak JR. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 1984;81:3684–3690. doi: 10.1063/1.448118. [DOI] [Google Scholar]
- 30.Hess B, Bekker H, Berendsen HJC, Fraaije JGEM. LINCS: A linear constraint solver for molecular simulations. J. Comput. Chem. 1997;18:1463–1472. doi: 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H. [DOI] [Google Scholar]
- 31.Erijman A, Dantes A, Bernheim R, Shifman JM, Peleg Y. Transfer-PCR (TPCR): a highway for DNA cloning and protein engineering. J. Struct. Biol. 2011;175:171–177. doi: 10.1016/j.jsb.2011.04.005. [DOI] [PubMed] [Google Scholar]
- 32.Fasman GD. Practical Handbook of Biochemistry and Molecular Biology. CRC Press; 1989. [Google Scholar]
- 33.Niklasson M, et al. Robust and convenient analysis of protein thermal and chemical stability. Protein Sci. 2015;24:2055–2062. doi: 10.1002/pro.2809. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Wyatt PJ. Light-scattering and the absolute characterization of macromolecules. Anal. Chim. Acta. 1993;272:1–40. doi: 10.1016/0003-2670(93)80373-S. [DOI] [Google Scholar]
- 35.Shimizu N, et al. BL-10C, the small-angle x-ray scattering beamline at the photon factory. AIP Conf. Proc. 2019;2054:060041. doi: 10.1063/1.5084672. [DOI] [Google Scholar]
- 36.Shimizu N, et al. Software development for analysis of small-angle X-ray scattering data. AIP Conf. Proc. 2016;1741:050017. doi: 10.1063/1.4952937. [DOI] [Google Scholar]
- 37.Svergun DI. Determination of the regularization parameter in indirect-transform methods using perceptual criteria. J. Appl. Crystallogr. 1992;25:495–503. doi: 10.1107/S0021889892001663. [DOI] [Google Scholar]
- 38.Franke D, et al. ATSAS 2.8: a comprehensive data analysis suite for small-angle scattering from macromolecular solutions. J. Appl. Crystallogr. 2017;50:1212–1225. doi: 10.1107/S1600576717007786. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Glatter O, Kratky O. Small-Angle X-Ray Scattering. Academic Press; 1982. [DOI] [PubMed] [Google Scholar]
- 40.Franke D, Svergun DI. DAMMIF, a program for rapid ab-initio shape determination in small-angle scattering. J. Appl. Crystallogr. 2009;42:342–346. doi: 10.1107/S0021889809000338. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Volkov VV, Svergun DI. Uniqueness of ab initio shape determination in small-angle scattering. J. Appl. Crystallogr. 2003;36:860–864. doi: 10.1107/S0021889803000268. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Svergun DI. Restoring low resolution structure of biological macromolecules from solution scattering using simulated annealing. Biophys. J. 1999;76:2879–2886. doi: 10.1016/S0006-3495(99)77443-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Pettersen EF, et al. UCSF Chimera—a visualization system for exploratory research and analysis. J. Comput. Chem. 2004;25:1605–1612. doi: 10.1002/jcc.20084. [DOI] [PubMed] [Google Scholar]
- 44.Valentini E, Kikhney AG, Previtali G, Jeffries CM, Svergun DI. SASBDB, a repository for biological small-angle scattering data. Nucl. Acids Res. 2015;43:D357–363. doi: 10.1093/nar/gku1047. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Kikhney AG, Borges CR, Molodenskiy DS, Jeffries CM, Svergun DI. SASBDB: towards an automatically curated and validated repository for biological scattering data. Protein Sci. 2020;29:66–75. doi: 10.1002/pro.3731. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.